Introduction: Non-chemotherapy drug-induced agranulocytosis (NCDIA) is a serious adverse reaction that significantly increases the risk of life-threatening infections. Although the association between ...

Fourth quarter 2024 CAPLYTA net product sales grew to $199.2 million, representing a 51% increase over the same period in 2023 Full year 2024 CAPLYTA net product sales were $680.5 million, ...

2, 3 The following case represents the third reported incident of agranulocytosis associated with the administration of acetazolamide. A 68-year-old man was readmitted to this hospital on December ...